IGF-1 and insulin increased the proportion of cells with metabolically active mitochondria (cell viability) of stromal and cancer cells by between 13 and 55% (HMEC-1 in high glucose with insulin and WiDr in high glucose with IGF-1, respectively). The gene discussed is IGF1; the disease is cancer.